1 Blood and labile blood products may only be used for homologous transfusions if the leucocytes have been depleted in a validated state-of-the-art scientific or technical procedure.
2 Plasma may only be used for homologous transfusions if, in addition to the safety measure described in paragraph 1 and the tests described in Article 30:
3 Platelet concentrates may only be used in Switzerland if appropriate measures are taken to mitigate the risk of bacterial contamination.
4 Unused autologous donations must not be used for homologous transfusions or to manufacture blood products.
1
2
3
4
This document is not an official publication. Only the publication of the Federal Chancellery is legally binding.
Dies ist keine amtliche Veröffentlichung. Massgebend ist allein die Veröffentlichung durch die Bundeskanzlei.